All posts
14550 total · page 181 of 291
India crossing 30 billion dollars in pharma exports for FY25 and what it means for global competitiveness
India's pharma exports soar, boosting global market presence.
Government proposals to ease clinical trial rules and what it means for R&D and innovation
New rules could boost innovation in clinical trials significantly.
Adoption of Indian Pharmacopoeia by international markets and its significance for trade
Indian Pharmacopoeia boosts global trade in pharmaceuticals.
Large acquisitions in Indian pharma and what consolidation means for competition and scale
Mergers in Indian pharma reshape competition and market dynamics.
How regulatory clarity in biologics approval can open new growth frontiers in Indian pharma
Regulatory clarity can boost India's biologics sector significantly.
Global companies setting up tech innovation centres in India and what it means for R&D
Global firms are boosting R&D by launching tech hubs in India.
The impact of pharma-grade sugar export policies on domestic supply and global trade
Pharma-grade sugar policies reshape markets and trade dynamics.
India’s dependence on imported APIs and strategies for boosting local manufacturing
India seeks to reduce reliance on imported APIs through local strategies.
State-level pharma and medical device policies and their role in attracting investment
State policies shape the future of pharma investments significantly.
Challenges and volatility in pharma stocks in H1 2025 and the impact on investor sentiment
Pharma stocks faced turmoil, shaking investor confidence.
How exporters are managing supply chain risks amid API import dependence
Exporters tackle supply chain risks in a shifting landscape.
Pharma exporters seeking rollback of export bans on India-only drugs and its policy implications
Pharma exporters push to lift bans on India-only drug exports.
How Indian pharma companies are building strength in immunotherapy and biologics
Indian pharma companies are innovating in immunotherapy breakthroughs.
Policy environment around medical devices and incentives for growth
Navigating policies can fuel medical device innovation and growth.
Pricing pressures versus value growth in therapy segments such as cardiac and diabetes
Balancing pricing pressures with value growth in therapies.
Acquisition trends in Indian pharma and the growing focus on oncology portfolios
Indian pharma shifts focus to oncology through strategic acquisitions.
Global regulatory pressures and how Indian pharma is adapting quality and compliance standards
Indian pharma is evolving to meet global compliance demands.
The state of clinical trials in India and recent reforms to attract global studies
India's reforms boost clinical trials, attracting global interest.
The rising role of specialty drugs and biologics in India’s export mix
India's specialty drugs are transforming global healthcare exports.
The future of Indian obesity drug pipelines and the global race to develop novel molecules
India's obesity drug pipeline is vital for global health innovation.
Trends in domestic consumption versus exports in Indian pharmaceuticals
India's pharmaceutical sector is evolving, balancing local needs and global demands.
Evolution of pharma R&D funding and collaboration trends in India
India's pharma R&D funding is evolving with new collaborations.
Digitization in pharma regulation with e-governance and approval portals
E-governance transforms pharma regulation and approval processes.
Opportunities in neglected and rare diseases for Indian pharma innovation
Unlocking new potential in rare disease innovation in India.
Policy reforms shaping India as a manufacturing hub for pharma and devices
India's policy reforms are transforming its pharma manufacturing landscape.
Effect of geopolitical tensions on pharma raw material sourcing strategies
Geopolitical tensions reshape pharma sourcing strategies dramatically.
The role of pharma in achieving India’s public health and affordability goals
Pharma plays a crucial role in enhancing India’s public health.
How stock market performance is influencing pharma investor confidence
Pharma stocks are swinging as market trends shift investor trust.
Quality standards and the quest for compliance with USFDA and EU GMP norms
Navigating USFDA and EU GMP norms ensures product safety.
Impact of price erosion after patent expiry with case studies from recent launches
Price erosion post-patent expiry reshapes market dynamics.
How mergers and acquisitions are reshaping the competitive landscape
Mergers and acquisitions are redefining industry dynamics.
The outlook for biotech and biosimilars in the Indian market
India's biotech and biosimilars market shows promising growth.
The rising importance of wellness and preventive care in pharma portfolios
Wellness and preventive care are reshaping pharma strategies.
Venture capital and startup trends in Indian pharma and biotech
Exploring the rise of venture capital in India's pharma sector.
Talent and skill development challenges in pharma manufacturing
Pharma manufacturing faces urgent talent and skill gaps.
Export incentives and trade policy changes affecting pharma companies
Pharma firms navigate new export incentives and trade shifts.
Regulatory oversight of pharma advertising and promotion in India
India tightens regulations on pharma advertising practices.
Sustainability and environmental compliance in Indian pharma production
Indian pharma is embracing sustainability for a greener future.
Price regulation and updates to Drug Price Control Orders
Exploring the impact of Drug Price Control Orders on healthcare.
The role of generics versus branded generics in the Indian healthcare system
Generics offer affordability, but branded generics build trust.
Pharma innovation clusters and their potential for scaling research
Pharma clusters boost collaboration, driving research breakthroughs.
Investment in local API parks and their expected outcomes
Local API parks promise economic growth and community benefits.
Public-private partnerships in pharma manufacturing and development
Collaborative efforts boost innovation in pharma development.
Patent law reforms and their implications for generics and innovators
Patent law reforms reshape the landscape for generics and innovators.
AI and machine learning applications in Indian drug discovery
AI is transforming drug discovery in India, boosting innovation.
Telemedicine and pharmaceutical delivery regulation post COVID
Post-COVID, telemedicine regulations are rapidly evolving.
Ethical sourcing and supply chain transparency in pharma ingredients
Ensuring transparency in pharma sourcing builds trust and safety.
Counterfeit and substandard drugs and policy efforts to address them
Combatting counterfeit drugs requires urgent global policy reform.
How India is preparing for future pandemics with vaccine capacity
India boosts vaccine production to combat future pandemics.
How Indian pharma is leveraging global partnerships and licensing deals
Indian pharma thrives through global partnerships and licensing.